Kuruswamy Thurai Prasad

Kuruswamy Thurai Prasad

Auto-generated profile, based on publicly available information

Kuruswamy Thurai Prasad

Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2023 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
RARitesh Agarwal
Ritesh Agarwal
VMValliappan Muthu
Valliappan Muthu
ISInderpaul Sehgal
Inderpaul Sehgal
SDSahajal Dhooria
Sahajal Dhooria
KPKuruswamy Thurai Prasad
Kuruswamy Thurai Prasad
ACArunaloke Chakrabarti
Arunaloke Chakrabarti

1 March 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
RARitesh Agarwal
Ritesh Agarwal
VMValliappan Muthu
Valliappan Muthu
ISInderpaul Sehgal
Inderpaul Sehgal
SDSahajal Dhooria
Sahajal Dhooria
KPKuruswamy Thurai Prasad
Kuruswamy Thurai Prasad
ACArunaloke Chakrabarti
Arunaloke Chakrabarti
Background: The prevalence of aspergillus sensitization (AS) and allergic bronchopulmonary aspergillosis (ABPA) in asthmatic children remains unclear. Objective: To systematically review the literature to estimate the prevalence of AS and ABPA in children with bronchial asthma. Methods: We searched the PubMed and Embase databases for studies reporting the prevalence of AS or ABPA in pediatric asthma. The primary outcome was to assess the prevalence of AS, while the secondary outcome was to evaluate the prevalence of ABPA. We pooled the prevalence estimates using a random effects model. We also calculated the heterogeneity and publication bias. Results: Of the 11,695 records retrieved, 16 studies with 2468 asthmatic children met the inclusion criteria. Most studies were published from tertiary centers. The pooled prevalence of AS in asthma (15 studies; 2361 subjects) was 16.1% (95% confidence intervals [CI], 9.3–24.3). The prevalence of AS was significantly higher in prospective studies, studies from India, and those from developing countries. The pooled prevalence of ABPA in asthma (5 studies; 505 children) was 9.9% (95% CI, 0.81–27.6). There was significant heterogeneity and publication bias for both outcomes. Conclusions: We found a high prevalence of AS and ABPA in asthmatic children. There is a need for community-based studies from different ethnicities using a standard methodology to ascertain the true prevalence of AS and ABPA in pediatric asthma.

1 June 2020 in Current Problems in Cancer
Verified
Journal Article
Closed access
APAmol Patel
Amol Patel
UBUllas Batra
Ullas Batra
KPKuruswamy Thurai Prasad
Kuruswamy Thurai Prasad
DDDeepak Dabkara
Deepak Dabkara
JGJoydeep Ghosh
Joydeep Ghosh
BBBivas Biswas
Bivas Biswas


1 June 2020 in Current Problems in Cancer
Verified
Journal Article
Closed access
AGAvneet Garg
Avneet Garg
UBUllas Batra
Ullas Batra
PCPriyanshu Choudhary
Priyanshu Choudhary
DJDeepali Jain
Deepali Jain
SKSachin Khurana
Sachin Khurana
AMAnant Mohan
Anant Mohan

8 April 2022 in Chest
Verified
Journal Article
Closed access
SDSahajal Dhooria
Sahajal Dhooria
ABAmanjit Bal
Amanjit Bal
ISInderpaul Sehgal
Inderpaul Sehgal
KPKuruswamy Thurai Prasad
Kuruswamy Thurai Prasad
DKDharambir Kashyap
Dharambir Kashyap
AAAshutosh Nath Aggarwal
Ashutosh Nath Aggarwal